Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report

Eugene Choi1, Junghwan Lee2, Youngsoo Park1

  • 1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

This study reports a rare case of a solitary Peutz-Jeghers type polyp in the duodenum. The polyp was covered with heterotopic gastric-type epithelium, challenging the typical definition of hamartomatous polyps.

Area of Science:

  • Gastroenterology
  • Pathology
  • Genetics

Background:

  • Peutz-Jeghers syndrome is characterized by gastrointestinal hamartomatous polyps, mucocutaneous pigmentation, and a family history or STK11/LTB1 mutation.
  • Solitary Peutz-Jeghers type polyps lack the full diagnostic criteria for Peutz-Jeghers syndrome but share histological features.
  • Hamartomatous polyps are defined by the abnormal overgrowth of indigenous epithelial components.

Observation:

  • A 47-year-old female presented with a solitary polyp in the duodenum.
  • The patient exhibited no mucocutaneous symptoms or family history of Peutz-Jeghers syndrome.
  • Microscopic examination revealed a Peutz-Jeghers type hamartomatous polyp.

Findings:

  • The duodenal polyp was covered with heterotopic gastric-type foveolar epithelium.
  • This histological feature represents a proliferation of a heterotopic component, deviating from the standard definition of hamartomatous polyps.
  • The case highlights an unusual presentation of a solitary Peutz-Jeghers type polyp.

Implications:

  • This case expands the understanding of Peutz-Jeghers type polyp morphology.
  • It suggests that heterotopic epithelium can be a feature of solitary hamartomatous polyps.
  • Further research may be needed to clarify the pathogenesis and classification of such polyps.

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
250
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
154
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
254
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
173
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
659
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
759